New information has prompted revision of the conceptual framework for considering the epidemiology and virology of viral hepatitis. The means are now at hand to identify infections due to either Hepatitis A or B, as well as to implicate other etiologic agents in hepatitis. Immunologic evidence of variation in the antigens associated with Hepatitis B, and possibly in Hepatitis A, may explain some well known epidemiologic phenomena and has important implications in immune serum globulin prophylaxis. The ambiguous relationship of antigenemia and viremia in Hepatitis B is explored in relation to the hepatitis hazard of blood products, to trials of immune serum globulin, and to the potential role of the carrier-health worker in hepatitis transmission. The emerging concept of non-parenteral transmission of Hepatitis B is reviewed and future developments in the production of hepatitis vaccines and in experimental viral hepatitis in non-human primates is briefly discussed.
Since we last reviewed the epidemiology of viral hepatitis (1) there have been a number of advances in our knowledge of the agents responsible for this illness and a greater appreciation of the diverse modes of transmission by which hepatitis may be spread. Despite, or in some instances because of, these new observations in both the laboratory and the field, the conceptual framework within which one might consider the epidemiology of viral hepatitis has become more rather than less complex. The available voluminous literature dealing with the Hepatitis B surface antigen (HB,Ag) will not be discussed in detail since this has been the object of a number of recent reviews. I would prefer to emphasize in these brief remarks a few selected areas of continuing controversy in which conceptual turnabouts are likely to occur, and others which have not yet received adequate attention but will certainly be the subject of future investigations.
AGENTS RESPONSIBLE FOR VIRAL HEPATITIS The Hepatitis B virus (HBV) is now believed to contain antigenic material in its core (HB,Ag) as well as on its surface (HB,Ag (8) .
In addition to infection with known viruses, the existence of unidentified hepatitisinducing agents may now be approached by means of exclusion. It would appear likely that hepatitis viruses other than A and B, e.g., C, D or E, may exist and may be more commonly encountered than was previously believed. The observation that the incidence of transfusion-associated hepatitis has remained nearly constant despite implementation of screening of blood donors, albeit imperfectly, for HB,Ag, during a period in which Type A hepatitis has not increased in frequency (9) (26) . Studies of apparently healthy blood donors have also rovealed the presence in 6-30% of anti-HB. (27) . Both pieces of data suggest that inapparent HBV infection is not uncommon, and that infection had been acquired by contact with asymptomatic infected cases or carriers. Further circumstantial evidence, often cited to support the concept of person-to-person fecal-oral HBV infection, is the high prevalence rate of HB,Ag and anti-HB, in certain tropical and subtropical developing populations (28) . It has been assumed, because of generally low levels of hygiene and population crowding in these nations, that HBV infection has been acquired by fecal-oral spread.
These interpretations are difficult to reconcile with previous observations that HBV infections are not readily spread from person to person, except by means of shared needles. It is noteworthy and unfortunate that much of the data on sporadic hepatitis in adults has been collected during the recent international epidemic of parenteral drug abuse, and the value of the absence of parenteral exposure history must, in at least some instances, be questioned. Whether parenteral spread, by repeated use of scarification needles, lancets, vaccination equipment, or mechanical transmission by biting insects, is important in developing countries must be clarified in future studies. The role of minor breaks in the integument and mucous membranes in the transfer of infection, as distinct from personal contact, requires further exploration. This mechanism of transmission of Hepatitis B was apparently responsible, some years ago, for a large outbreak of hepatitis among trackfinders who suffered multiple lacerations, scratches, and abrasions of their uncovered skin (29) .
In contrast to Hepatitis A, available data have failed to incriminate HBV in either food or water-borne epidemics of hepatitis. A special case may exist for shellfish-associated hepatitis which has been described in both epidemic and endemic forms (1) . The recent recovery of HB,Ag from clams (30) has implications which may yet alter our concepts of HBV infection through common vehicles.
Whether this is a real epidemiologic entity in the spread of HBV is unknown.
Non-parenteral epidemics of Hepatitis B are most unusual. Only two such contact-associated large outbreaks have been adequately described to date. The first of these occurred among U.S. Navy personnel inoculated with plasma in a study of the efficacy of influenza vaccine (31 (33) . Furthermore, in a study of secondary attack rates of HBV infection among household contacts of hemodialysis patients, marital partners were affected 14 times more frequently than children and non-spouse adults (34) . Although sexual transmission may explain these differential rates, it is also possible that spouses were more intimately exposed to Once these agents are grown in tissue culture systems, it is still likely that at least 5 years and probably 10 years will elapse before a specific hepatitis vaccine is commerically available.
EXPERIMENTAL VIRAL HEPATITIS
One of the most important developments in viral hepatitis research has been the transmission of both Hepatitis A and B to non-human primates. As recently outlined (38) , exploitation of these experimental models should provide new information concerning 1) host factors which determine the localization of hepatitis viruses in the liver, 2) biochemical pathology of viral liver disease, 3) modification of the response to infection by immunological, humoral, and genetic factors, 4) the potential role of antiviral chemotherapy in hepatitis, and 5) the role of immune mechanisms in recovery from or perpetuation of viral induced liver disease. These areas will be fertile grounds for new investigatons.
CONCLUSION
One may conclude by noting that exciting information has become available in recent years and that knowledge of viral hepatitis will certainly continue to expand. Although a number of challenges lie ahead, the complexities of the virology and epidemiology of viral hepatitis will eventually be unraveled and there will ultimately be no necessity for frequent revisions of the conceptual framework within which we attempt to understand this group of diseases.
